# Abbott Laboratories (ABT) — Q2-2021 Earnings Results

**Report date:** 2021-07-22 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q2-2021

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Down 0.6%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.17 | N/A | +16.19% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No forward guidance data is available.

### What It Means

Abbott Laboratories reported an EPS of $1.17, exceeding expectations by 16.19%. However, the stock reacted negatively, declining by 0.6%. This suggests that despite the earnings beat, investors may have had concerns about other aspects of the company's performance or future outlook.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q2-2021_